Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2656360 | 0.89 | GCK (0.80) | GCKKCNH2 | |
| SCHEMBL4106470 | 0.89 | GCK (0.77) | GCKKCNH2 | |
| SCHEMBL2653729 | 0.89 | GCK (0.77) | GCKKCNH2 | |
| SCHEMBL14018664 | 0.88 | GCK (0.61) | GCKKCNH2 | |
| SCHEMBL2660795 | 0.88 | GCK (0.64) | GCKKCNH2 | |
| SCHEMBL2659739 | 0.80 | GCK (0.54) | GCKKCNH2 | |
| SCHEMBL4776916 | 0.80 | GCK (0.79) | GCKKCNH2 | |
| SCHEMBL14349646 | 0.80 | GCK (0.54) | GCKKCNH2 | |
| SCHEMBL2658745 | 0.80 | GCK (0.79) | GCKKCNH2 | |
| SCHEMBL2653816 | 0.80 | GCK (0.80) | GCKKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1992623-A1 | Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes | Astra Zeneca AB (SE) | 2008-11-19 | — | — | EP | disclosed |